Abstract
Gastric cancer is the second most common cancer in the world. In the United States gastric cancer has a poor prognosis since it is usually diagnosed at a late stage. PET/MRI imaging can aid in the initial diagnosis of disease and has the ability to detect abnormal metabolic activity in normal-sized regional lymph nodes with a high accuracy. It can also help to predict treatment response to chemotherapy in patients with unresectable cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Huang Z, Xie DH, Guo L, Hu CH, Fang X, Meng Q, et al. The utility of MRI for pre-operative T and N staging of gastric carcinoma: a systematic review and meta-analysis. Br J Radiol. 2015;88:20140552.
Lee DH, Kim SH, Im SA, Oh DY, Kim TY, Han JK. Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study. Euro Radiol. 2016;26:2771–8.
Lim JS, Yun MJ, Kim MJ, Hyung WJ, Park MS, Choi JY, et al. CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2006;26:143–56.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Matthews, R. (2018). Gastric Adenocarcinoma. In: PET/MR Imaging . Springer, Cham. https://doi.org/10.1007/978-3-319-65106-4_65
Download citation
DOI: https://doi.org/10.1007/978-3-319-65106-4_65
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65105-7
Online ISBN: 978-3-319-65106-4
eBook Packages: MedicineMedicine (R0)